4.6 Article

A theoretical framework to model DSC-MRI data acquired in the presence of contrast agent extravasation

期刊

PHYSICS IN MEDICINE AND BIOLOGY
卷 54, 期 19, 页码 5749-5766

出版社

IOP PUBLISHING LTD
DOI: 10.1088/0031-9155/54/19/006

关键词

-

资金

  1. National Institutes of Health [1K25-EB005936, 2R25-CA092043, 1K99-CA127599, R01 EB001452]

向作者/读者索取更多资源

Dynamic susceptibility contrast (DSC) MRI methods rely on compartmentalization of the contrast agent such that a susceptibility gradient can be induced between the contrast-containing compartment and adjacent spaces, such as between intravascular and extravascular spaces. When there is a disruption of the blood-brain barrier, as is frequently the case with brain tumors, a contrast agent leaks out of the vasculature, resulting in additional T(1), T(2) and T(2)* relaxation effects in the extravascular space, thereby affecting the signal intensity time course and reducing the reliability of the computed hemodynamic parameters. In this study, a theoretical model describing these dynamic intra-and extravascular T(1), T(2) and T(2)* relaxation interactions is proposed. The applicability of using the proposed model to investigate the influence of relevant MRI pulse sequences (e.g. echo time, flip angle), and physical (e.g. susceptibility calibration factors, pre-contrast relaxation rates) and physiological parameters (e.g. permeability, blood flow, compartmental volume fractions) on DSC-MRI signal time curves is demonstrated. Such a model could yield important insights into the biophysical basis of contrast-agent-extravasastion-induced effects on measured DSC-MRI signals and provide a means to investigate pulse sequence optimization and appropriate data analysis methods for the extraction of physiologically relevant imaging metrics.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Radiology, Nuclear Medicine & Medical Imaging

Patient specific, imaging-informed modeling of rhenium-186 nanoliposome delivery via convection-enhanced delivery in glioblastoma multiforme

Ryan T. Woodall, David A. Hormuth II, Chengyue Wu, Michael R. A. Abdelmalik, William T. Phillips, Ande Bao, Thomas J. R. Hughes, Andrew J. Brenner, Thomas E. Yankeelov

Summary: The study presents a computational fluid dynamics approach to predict the spatial distribution of Re-186-nanoliposomes for individual patients with recurrent glioblastoma multiforme. The models were calibrated and validated using patient-specific pre-operative MRI data and showed potential for optimizing catheter placement in future studies using convection-enhanced delivery.

BIOMEDICAL PHYSICS & ENGINEERING EXPRESS (2021)

Article Engineering, Biomedical

Modeling of Glioma Growth With Mass Effect by Longitudinal Magnetic Resonance Imaging

Birkan Tunc, David A. Hormuth, George Biros, Thomas E. Yankeelov

Summary: This study evaluated the performance of three mathematical models of tumor growth using MRI data from a murine model of glioma. The RDM model most accurately predicts tumor growth, while the RDAM model demonstrates the least variation in estimates of diffusion coefficient and proliferation rate. The mathematical models successfully capture tumor development and mass effect observed in experiments.

IEEE TRANSACTIONS ON BIOMEDICAL ENGINEERING (2021)

Article Medicine, Research & Experimental

Associations Between Dynamic Contrast Enhanced Magnetic Resonance Imaging and Clinically Relevant Histopathological Features in Breast Cancer: A Multicenter Analysis

Alexey Surov, Jin You Kim, Marco Aiello, Wei Huang, Thomas E. Yankeelov, Andreas Wienke, Maciej Pech

Summary: In this study, the relationships between quantitative dynamic contrast-enhanced magnetic resonance imaging (DCE MRI) and prognostic factors in breast cancer (BC) were investigated. The results showed that DCE MRI parameters were positively correlated with KI-67, but could not be used as reliable markers for hormone receptor status, tumor stage, and grade in BC. However, K-trans could discriminate lesions with high and low proliferation activity.

IN VIVO (2022)

Article Radiology, Nuclear Medicine & Medical Imaging

Multi-Site Concordance of Diffusion-Weighted Imaging Quantification for Assessing Prostate Cancer Aggressiveness

Sean D. McGarry, Michael Brehler, John D. Bukowy, Allison K. Lowman, Samuel A. Bobholz, Savannah R. Duenweg, Anjishnu Banerjee, Sarah L. Hurrell, Dariya Malyarenko, Thomas L. Chenevert, Yue Cao, Yuan Li, Daekeun You, Andrey Fedorov, Laura C. Bell, C. Chad Quarles, Melissa A. Prah, Kathleen M. Schmainda, Bachir Taouli, Eve LoCastro, Yousef Mazaheri, Amita Shukla-Dave, Thomas E. Yankeelov, David A. Hormuth, Ananth J. Madhuranthakam, Keith Hulsey, Kurt Li, Wei Huang, Wei Huang, Mark Muzi, Michael A. Jacobs, Meiyappan Solaiyappan, Stefanie Hectors, Tatjana Antic, Gladell P. Paner, Watchareepohn Palangmonthip, Kenneth Jacobsohn, Mark Hohenwalter, Petar Duvnjak, Michael Griffin, William See, Marja T. Nevalainen, Kenneth A. Iczkowski, Peter S. LaViolette

Summary: 14 site-specific parametric fitting algorithms were compared on DWI data, with K, DK, and MEADC showing higher prostate cancer detection capability compared to bi-exponential parameters. Post-processing decisions on DWI data can significantly impact sensitivity and specificity in prostate cancer studies.

JOURNAL OF MAGNETIC RESONANCE IMAGING (2022)

Article Computer Science, Artificial Intelligence

An in silico validation framework for quantitative DCE-MRI techniques based on a dynamic digital phantom

Chengyue Wu, David A. Hormuth, Ty Easley, Victor Eijkhout, Federico Pineda, Gregory S. Karczmar, Thomas E. Yankeelov

Summary: This study introduces a dynamic digital phantom for validating dynamic contrast-enhanced magnetic resonance imaging methods, evaluates the performance of standard and ultra-fast acquisitions, and demonstrates the influence of acquisition parameters on image generation.

MEDICAL IMAGE ANALYSIS (2021)

Article Radiology, Nuclear Medicine & Medical Imaging

Disposable point-of-care portable perfusion phantom for quantitative DCE-MRI

Martin D. Holland, Andres Morales, Sean Simmons, Brandon Smith, Samuel R. Misko, Xiaoyu Jiang, David A. Hormuth, Chase Christenson, Roy P. Koomullil, Desiree E. Morgan, Yufeng Li, Junzhong Xu, Thomas E. Yankeelov, Harrison Kim

Summary: The DP4 phantom is reliable, portable, and capable of significantly improving the reproducibility of qDCE-MRI measurements.

MEDICAL PHYSICS (2022)

Article Radiology, Nuclear Medicine & Medical Imaging

Longitudinal FRET Imaging of Glucose and Lactate Dynamics and Response to Therapy in Breast Cancer Cells

Jianchen Yang, Tessa Davis, Anum S. Kazerouni, Yuan-I. Chen, Meghan J. Bloom, Hsin-Chih Yeh, Thomas E. Yankeelov, John Virostko

Summary: The study successfully transfected FRET reporters quantifying glucose and lactate concentration into breast cancer cell lines, allowing for tracking of nutrient dynamics and response to therapy. The FRET ratio from the reporters increased with ligand concentration and decreased over time for high initial concentrations, indicating the potential for monitoring metabolic changes in cancer cells.

MOLECULAR IMAGING AND BIOLOGY (2022)

Correction Radiology, Nuclear Medicine & Medical Imaging

Longitudinal FRET Imaging of Glucose and Lactate Dynamics and Response to Therapy in Breast Cancer Cells (Oct, 10.1007/s11307-021-01639-4, 2021)

Jianchen Yang, Tessa Davis, Anum S. Kazerouni, Yuan-I. Chen, Meghan J. Bloom, Hsin-Chih Yeh, Thomas E. Yankeelov, John Virostko

MOLECULAR IMAGING AND BIOLOGY (2022)

Article Oncology

A Multi-Compartment Model of Glioma Response to Fractionated Radiation Therapy Parameterized via Time-Resolved Microscopy Data

Junyan Liu, David A. Hormuth, Jianchen Yang, Thomas E. Yankeelov

Summary: This study proposes and validates a time-resolved mathematical model to predict the changes in tumor response to fractionated radiation. By experimentally verifying the model, it establishes a framework for quantitative characterization and prediction of the dynamic radiobiological response of gliomas to fractionated radiotherapy.

FRONTIERS IN ONCOLOGY (2022)

Article Biology

Generative adversarial network enables rapid and robust fluorescence lifetime image analysis in live cells

Yuan- Chen, Yin-Jui Chang, Shih-Chu Liao, Trung Duc Nguyen, Jianchen Yang, Yu-An Kuo, Soonwoo Hong, Yen-Liang Liu, H. Grady Rylander, Samantha R. Santacruz, Thomas E. Yankeelov, Hsin-Chih Yeh

Summary: In this study, Chen et al. introduced a new deep learning-based method called flimGANE to rapidly generate accurate and high-quality FLIM images even in the photon-starved conditions. flimGANE is particularly useful in fundamental biological research and clinical applications.

COMMUNICATIONS BIOLOGY (2022)

Article Oncology

Quantifying Tumor Heterogeneity via MRI Habitats to Characterize Microenvironmental Alterations in HER2+Breast Cancer

Anum S. Kazerouni, David A. Hormuth, Tessa Davis, Meghan J. Bloom, Sarah Mounho, Gibraan Rahman, John Virostko, Thomas E. Yankeelov, Anna G. Sorace

Summary: This study investigated tumor heterogeneity in a mouse model of HER2+ breast cancer using magnetic resonance imaging (MRI). The results showed that the baseline imaging phenotypes can predict therapy response, and there were correlations between imaging habitats and histological measures. These findings have potential implications for improving personalized treatment strategies for breast cancer patients.

CANCERS (2022)

Article Biochemistry & Molecular Biology

A Case Series Exploration of Multi-Regional Expression Heterogeneity in Triple-Negative Breast Cancer Patients

Qi Xu, Jaspreet Kaur, Dennis Wylie, Karuna Mittal, Hongxiao Li, Rishab Kolachina, Mohammed Aleskandarany, Michael S. Toss, Andrew R. Green, Jianchen Yang, Thomas E. Yankeelov, Shristi Bhattarai, Emiel A. M. Janssen, Jun Kong, Emad A. Rakha, Jeanne Kowalski, Ritu Aneja

Summary: This study explores the intratumoral heterogeneity (ITH) in triple-negative breast cancer (TNBC) by evaluating gene expression and imaging differences within the same tumor. The results show extensive intertumoral heterogeneity and regional ITH in gene expression and image-derived features in TNBC. Concerns are raised regarding gene expression based TNBC subtyping.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Oncology

Quantifying the Effects of Combination Trastuzumab and Radiation Therapy in Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer

Meghan J. Bloom, Patrick N. Song, John Virostko, Thomas E. Yankeelov, Anna G. Sorace

Summary: In vitro and in vivo studies have shown that combination trastuzumab and radiotherapy have an additive effect and can achieve similar efficacy as higher dose radiotherapy with fewer adverse effects. The combination therapy also showed potential in increasing immune infiltration.

CANCERS (2022)

Article Radiology, Nuclear Medicine & Medical Imaging

Co-Clinical Imaging Metadata Information (CIMI) for Cancer Research to Promote Open Science, Standardization, and Reproducibility in Preclinical Imaging

Stephen M. Moore, James D. Quirk, Andrew W. Lassiter, Richard Laforest, Gregory D. Ayers, Cristian T. Badea, Andriy Y. Fedorov, Paul E. Kinahan, Matthew Holbrook, Peder E. Z. Larson, Renuka Sriram, Thomas L. Chenevert, Dariya Malyarenko, John Kurhanewicz, A. McGarry Houghton, Brian D. Ross, Stephen Pickup, James C. Gee, Rong Zhou, Seth T. Gammon, Henry Charles Manning, Raheleh Roudi, Heike E. Daldrup-Link, Michael T. Lewis, Daniel L. Rubin, Thomas E. Yankeelov, Kooresh I. Shoghi

Summary: Preclinical imaging is critical for translational research in cancer, but there are complexities and regional differences. The NCI emphasizes the use of oncology models to study the biological and molecular basis of cancer prevention and treatment. To address the issues, the NCI conducted a survey and summarized the metadata requirements for reproducible quantitative co-clinical imaging to support translational imaging research.

TOMOGRAPHY (2023)

Article Radiology, Nuclear Medicine & Medical Imaging

Toward Practical Integration of Omic and Imaging Data in Co-Clinical Trials

Emel Alkim, Heidi Dowst, Julie DiCarlo, Lacey E. Dobrolecki, Anadulce Hernandez-Herrera, David A. Hormuth II, Yuxing Liao, Apollo McOwiti, Robia Pautler, Mothaffar Rimawi, Ashley Roark, Ramakrishnan Rajaram Srinivasan, Jack Virostko, Bing Zhang, Fei Zheng, Daniel L. Rubin, Thomas E. Yankeelov, Michael T. Lewis

Summary: Co-clinical trials involve evaluating therapeutics in both patients and patient-derived xenografts (PDX) to determine how well PDX responses match patient responses, in order to inform pre-clinical and clinical trials. The challenge lies in managing and analyzing the vast amount of data generated across different scales and species. To overcome this challenge, a web-based tool called MIRACCL is being developed to correlate MRI-based changes in tumor characteristics with mRNA expression data in a co-clinical trial setting.

TOMOGRAPHY (2023)

暂无数据